| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |